| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiotensin II receptors and drug discovery in cardiovascular disease
|
Dasgupta, Chiranjib
|
|
2011
|
16 |
1-2 |
p. 22-34
13 p.
|
artikel
|
| 2 |
Characteristics of orphan drug applications that fail to achieve marketing approval in the USA
|
Heemstra, Harald E.
|
|
2011
|
16 |
1-2 |
p. 73-80
8 p.
|
artikel
|
| 3 |
Characterization of protein therapeutics by mass spectrometry: recent developments and future directions
|
Chen, Guodong
|
|
2011
|
16 |
1-2 |
p. 58-64
7 p.
|
artikel
|
| 4 |
China's drug innovation and policy environment
|
Liang, Huigang
|
|
2011
|
16 |
1-2 |
p. 1-3
3 p.
|
artikel
|
| 5 |
Contents page 1
|
|
|
2011
|
16 |
1-2 |
p. i-
1 p.
|
artikel
|
| 6 |
Contents page 2
|
|
|
2011
|
16 |
1-2 |
p. iii-
1 p.
|
artikel
|
| 7 |
Creativity, innovation and lean sigma: a controversial combination?
|
Johnstone, Craig
|
|
2011
|
16 |
1-2 |
p. 50-57
8 p.
|
artikel
|
| 8 |
Early chemical development at Legacy Wyeth Research
|
O’Brien, Michael K.
|
|
2011
|
16 |
1-2 |
p. 81-88
8 p.
|
artikel
|
| 9 |
New avenues to target Wnt/β-catenin signaling
|
Verkaar, Folkert
|
|
2011
|
16 |
1-2 |
p. 35-41
7 p.
|
artikel
|
| 10 |
Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options
|
Wipfler, Peter
|
|
2011
|
16 |
1-2 |
p. 8-21
14 p.
|
artikel
|
| 11 |
Re-formulating drugs and vaccines for intranasal delivery: maximum benefits for minimum risks?
|
Watts, Peter J.
|
|
2011
|
16 |
1-2 |
p. 4-7
4 p.
|
artikel
|
| 12 |
The graphical representation of ADME-related molecule properties for medicinal chemists
|
Ritchie, Timothy J.
|
|
2011
|
16 |
1-2 |
p. 65-72
8 p.
|
artikel
|
| 13 |
Understanding infectious agents from an in silico perspective
|
Tong, Joo Chuan
|
|
2011
|
16 |
1-2 |
p. 42-49
8 p.
|
artikel
|
Tijdschrift beschrijving